Alcohol consumption and mortality in patients with mild Alzheimer's disease: a prospective cohort study
- PMID: 26656463
- PMCID: PMC4679998
- DOI: 10.1136/bmjopen-2015-007851
Alcohol consumption and mortality in patients with mild Alzheimer's disease: a prospective cohort study
Abstract
Objective: To investigate the association between alcohol consumption and mortality in patients recently diagnosed with mild Alzheimer's disease (AD).
Design: A post hoc analysis study based on a clinical trial population.
Setting: The data reported were collected as part of the Danish Alzheimer's Intervention Study (DAISY), a longitudinal multicentre randomised controlled study on the efficacy of psychosocial intervention in patients with mild AD across five county districts in Denmark.
Participants: 321 patients with mild AD (Mini-Mental State Examination ≥ 20) were included. Data regarding current daily alcohol consumption were obtained from the patient's primary caregivers at inclusion.
Main outcome: All-cause mortality retrieved from The Danish Civil Registration System over a period of 36 months after baseline.
Results: Information about alcohol consumption was obtained from all 321 study participants: 8% were abstinent, 71% only had alcohol occasionally (1 or <1 unit/day), 17% had 2-3 units/day and 4% had more than 3 units/day. An analysis adjusted for a range of potential confounders demonstrated a reduced mortality for patients with moderate alcohol consumption (2-3 units/day): HR 0.23 (95% CI (0.08 to 0.69)) compared with patients who had 1 or <1 unit/day. Mortality was not significantly different in abstinent patients or in patients with an alcohol consumption of more than 3 units/day, compared with patients drinking 1 or <1 unit/day.
Conclusions: In this cohort of patients with mild AD, moderate alcohol consumption (2-3 units/day) was associated with a significantly lower mortality over a period of 36 months. Further studies are needed in this area. These may especially focus on the association between alcohol consumption and cognitive decline in patients with AD.
Keywords: GERIATRIC MEDICINE.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Similar articles
-
Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease.BMC Geriatr. 2016 Apr 19;16:87. doi: 10.1186/s12877-016-0262-x. BMC Geriatr. 2016. PMID: 27094158 Free PMC article. Clinical Trial.
-
Efficacy of psychosocial intervention in patients with mild Alzheimer's disease: the multicentre, rater blinded, randomised Danish Alzheimer Intervention Study (DAISY).BMJ. 2012 Jul 17;345:e4693. doi: 10.1136/bmj.e4693. BMJ. 2012. PMID: 22807076 Free PMC article. Clinical Trial.
-
Changes in Mini-Mental State Examination score in Alzheimer's disease patients after stopping habitual drinking.Psychogeriatrics. 2013 Jun;13(2):94-8. doi: 10.1111/psyg.12008. Psychogeriatrics. 2013. PMID: 23909966
-
A three-year follow-up on the efficacy of psychosocial interventions for patients with mild dementia and their caregivers: the multicentre, rater-blinded, randomised Danish Alzheimer Intervention Study (DAISY).BMJ Open. 2013 Nov 21;3(11):e003584. doi: 10.1136/bmjopen-2013-003584. BMJ Open. 2013. PMID: 24270834 Free PMC article.
-
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.Lancet Neurol. 2008 Jun;7(6):483-93. doi: 10.1016/S1474-4422(08)70090-5. Epub 2008 Apr 29. Lancet Neurol. 2008. PMID: 18450517 Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical